Seller record · Telehealth service

Mochi Health

By Peptide Alliance, Editorial publisherRecorded August 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: The buyer compares pharmacies and may fill at any pharmacy of choice, and no filling facility is named anywhere on the site. 1 more criterion also fails; see the table below.

At a glance

Mochi HealthTelehealth service

6/8criteria passed

Price: Semaglutide from $60, plus membership
Sells: compounded semaglutide, compounded tirzepatide, brand Zepbound, and 4 more
FDA letters: None on file

Visit Mochi Health See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded and brand GLP-1 drugs. It names four affiliated medical practices, and it lets the buyer choose the filling pharmacy.

Operating entity Mochi Health Corp., Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Mochi Health's terms and conditions
S2	Prescription gating	PASS	Mochi Health's eligibility page on its app site
S3	Pharmacy identification	FAIL	Mochi Health's terms and conditions; Mochi Health's weight loss page
S4	Compounding disclosure	PASS	Mochi Health's compounded semaglutide product page
S5	Analytical documentation	FAIL	Mochi Health's sitemap page
S6	Business address	PASS	Mochi Health's terms and conditions; Mochi Health's privacy policy
S7	Price disclosure	PASS	Mochi Health's compounded semaglutide product page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSFour affiliated medical practices are named, and no prescription issues unless a licensed Mochi clinician has assessed the buyer and written it.Source: Mochi Health's terms and conditions.

S2PASSThe first eligibility question, which asks the buyer's primary weight loss goal, stops the order.Source: Mochi Health's eligibility page on its app site.

S3FAILThe buyer compares pharmacies and may fill at any pharmacy of choice, and no filling facility is named anywhere on the site.Source: Mochi Health's terms and conditions; Mochi Health's weight loss page.

S4PASSCompounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality, printed directly under the price.Source: Mochi Health's compounded semaglutide product page.

S5FAILNo certificate, lot report or test document appears on the product page, the terms, or anywhere else on the site.Source: Mochi Health's sitemap page.

S6PASS333 Bush St., Suite #1200, San Francisco, CA 94104 in the terms; the privacy policy gives 161 Natoma St, San Francisco, CA 94105 instead.Source: Mochi Health's terms and conditions; Mochi Health's privacy policy.

S7PASSCompounded semaglutide is printed starting at 60 dollars, with membership at 39 dollars for the first month and 79 dollars per month afterward.Source: Mochi Health's compounded semaglutide product page.

S8PASSNo FDA warning letter names the entity, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, brand Zepbound, brand Wegovy, brand Ozempic, metformin, hair loss medications.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit Mochi Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.